However, there are some other studies in the literature which have suggested the negative association of EpCAM expression with tumor grade, invasion, and lymph node metastasis [48] and noted the correlation of a decreased expression of EpCAM with poor survival and cancer recurrence in CRC patients [21, 39, 65]. Here, EPCAM is linked to metastatic malignant neoplasm in the lymph nodes.